SCHEMBL22039870

SCHEMBL22039870

CN(C)c1ccc(/C=C/C(=O)c2cccc(Br)c2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 1.00
▸ KMT2A Q03164 5/20 1.00
▸ MEN1 O00255 4/20 1.00
▸ ALDH1A1 P00352 3/20 1.00
▸ POLB P06746 3/20 1.00
▸ LMNA P02545 3/20 1.00
▸ TLR9 Q9NR96 3/20 1.00
▸ L3MBTL1 Q9Y468 3/20 1.00
▸ TDP1 Q9NUW8 2/20 1.00
▸ ATM Q13315 2/20 1.00
▸ ALPG P10696 1/20 1.00
▸ NPSR1 Q6W5P4 1/20 1.00
▸ RECQL P46063 2/20 0.65
▸ CYP1B1 Q16678 2/20 0.61
▸ NPC1 O15118 2/20 0.61
▸ RAB9A P51151 2/20 0.61
▸ CASP3 P42574 1/20 0.61
▸ SMN1; SMN2 Q16637 1/20 0.61
▸ SENP8 Q96LD8 1/20 0.61
▸ SENP7 Q9BQF6 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11142982 1.00 MAPT (1.00) MAPTKMT2AMEN1ALDH1A1POLB
SCHEMBL11142194 0.86 MAPT (0.76) MAPTKMT2AMEN1ALDH1A1POLB
SCHEMBL11141638 0.86 MAPT (0.76) MAPTKMT2AMEN1ALDH1A1POLB
SCHEMBL1797522 0.85 P4HB (0.77) MAPTKMT2AMEN1ALDH1A1POLB
SCHEMBL1797521 0.85 P4HB (0.77) MAPTKMT2AMEN1ALDH1A1POLB
SCHEMBL3691513 0.85 MAPT (0.73) MAPTKMT2AMEN1ALDH1A1POLB
SCHEMBL3693538 0.85 MAPT (0.73) MAPTKMT2AMEN1ALDH1A1POLB
SCHEMBL27316538 0.84 MAPT (0.73) MAPTKMT2AMEN1ALDH1A1POLB
SCHEMBL11141582 0.84 MAPT (0.73) MAPTKMT2AMEN1ALDH1A1POLB
SCHEMBL5449315 0.84 MAPT (0.72) MAPTKMT2AMEN1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11180518-B2 Phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanoma MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2021-11-23 — — US disclosed
US-20200165279-A1 PHENYL-HETEROCYCLE-PHENYL DERIVATIVES FOR USE IN THE TREATMENT OR PREVENTION OF MELANOMA MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2020-05-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200165279-A1 PHENYL-HETEROCYCLE-PHENYL DERIVATIVES FOR USE IN THE TREATMENT OR PREVENTION OF MELANOMA TYR, MITF, VHL MAPT 3145/4885KMT2A 806/4885MEN1 464/4885
US-11180518-B2 Phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanoma TYR, MITF, VHL MAPT 3145/4885KMT2A 806/4885MEN1 464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback